EuroGCT Deliverable D4.7: Information collation, report on collation of existing information and links on where to seek information and guidance- Version 2.0

Résumé 0

Deliverable D.4.7 "Information collation - Report on collation of existing information andlinks on where to seek information and guidance" describes the methodology and toolsused for collecting and selecting information regarding gene and cell therapy development. Itfocuses on how the information is collated rather than summarising the collated informationitself.The published and subsequent output of the methodological reporting in this early-projectdeliverable is presented in D4.2. The collated information is presented in the EuroGCT websiteResearch Pathways section (https://www.eurogct.org/research-pathways) as a searchableand filterable database. New content developed by the EuroGCT project and signposting toadditional collated resources is now continually incorporated into this database, and this willcontinue throughout the duration of the project.The overall objective of WP4 is to develop an information hub for the research and regulatorycommunities, facilitating their access to high-quality information on the practical steps neededfor cell and gene-based therapy development at each stage of the product developmentprocess. This deliverable, on the means of information-gathering, constitutes the foundationof all information provision by WP4. It forms the basis of all deliverables within WP4, from pastdeliverables (D4.4 Regulator Engagement Strategy, D4.8 Initial Landscape Mapping, andD4.9 Initial Information on Practical Steps) to deliverables due now (D4.1 Landscape Mapping,and D4.2 Resources on Practical Steps), and future deliverables (D4.3 Searchable Map, D4.5Knowledge Sharing Function, and D4.6 Hub for the Research and Regulatory Communities).How the information is collated feeds into what information is selected, information quality andwhether it meets the needs of the stakeholders. It therefore affects every output from WP4.For this reason, it is of fundamental importance to report on the details of the approaches wehave taken. The field of gene and cell therapy is rapidly advancing, and so is the relevantscientific and legal information. The EuroGCT WP4 has been and will continue to review andupdate our methodology for collecting this information throughout the project span. Updateswithin the current reporting period have been reflected in this report within relevant sectionsand annexes.